EASY: Essential Acute Stroke Care in Low Resource Settings: a Pilot studY

Sponsor
The George Institute (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04157231
Collaborator
World Heart Federation (Other)
300
4
2
11
75
6.8

Study Details

Study Description

Brief Summary

An investigator-initiated, evaluator-blinded, prospective, multi centre, before-and-after, effectiveness-implementation hybrid design study to assess the feasibility of essential acute stroke care in a low resource setting

Condition or Disease Intervention/Treatment Phase
  • Other: Acute stroke care Intervention arm
N/A

Detailed Description

This is a multicentre, before and after, effectiveness-implementation hybrid study design with blinded outcome assessment. Patients admitted to the participating hospitals will be managed under usual care conditions for three months (control arm). This will be followed by the training of the doctors and nurses in those hospitals on essential acute stroke care management. Patient management for the following three months after the training (intervention) will then be assessed to evaluate its impact on the care and clinical outcome of the patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
A before and after, effectiveness-implementation hybrid study design with blinded outcome assessment will be conducted. This type 1 effectiveness-implementation hybrid design will test the essential acute stroke care management plan and secondarily gather data to inform subsequent research trialsA before and after, effectiveness-implementation hybrid study design with blinded outcome assessment will be conducted. This type 1 effectiveness-implementation hybrid design will test the essential acute stroke care management plan and secondarily gather data to inform subsequent research trials
Masking:
Single (Outcomes Assessor)
Masking Description:
The clinical outcome will be assessed by a blinded assessor
Primary Purpose:
Supportive Care
Official Title:
Essential Acute Stroke Care in Low Resource Settings: a Pilot Study
Anticipated Study Start Date :
May 30, 2022
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care

Usual care to be provided to patients as per hospital guidelines for 3 months

Other: Intervention arm

The intervention consists of training and education of the site staff about the treatment protocol for the different components of the management plan will be provided on two occasions. This intervention will run for 3 months. Refresher training will be given monthly during the intervention.

Other: Acute stroke care Intervention arm
Training and education of the site staff about the treatment protocol for the different components of the management plan will be provided on two occasions. The aim of these sessions will be to educate stroke champions and other site staff on the management protocols. Available training resources will be accessed (including online materials) and simulation training will be used. New skills such as dysphagia assessment will be emphasized based on existing knowledge and competencies. After training, staff will have another assessment (Post-test) in order to determine whether they have been adequately trained and are able to adhere to the essential acute stroke care management plan. A standardised Power Point presentation and accompanying handouts will be made available for further use in the ward. Refresher training will be provided monthly during the intervention.

Outcome Measures

Primary Outcome Measures

  1. Adherence [30 days]

    Primary Outcome Measure: Adherence to the predefined components of the essential acute stroke care management plan Adherence will be expressed as all or none measure and is defined as the proportion of patients who receive all the components of acute stroke care management for which the patient is eligible. Adherence will also be expressed as a composite measure, which is defined as the total number of eligible components performed divided by the total number of components for which the patient was eligible.

Secondary Outcome Measures

  1. Death or disability [30 Days]

    Death or disability as measured by Modified Rankin Scale (mRS) at 30 days. The mRS is a disability scale that ranges from 0 (no symptoms) to 6 (death).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults (age ≥18 years)

  • A clinical or imaging-based diagnosis of acute stroke (ischemic or haemorrhagic) within 72 hours of stroke symptom onset

  • Provision of written informed consent

  • Subjects in observational, natural history and/or epidemiological studies not involving an intervention are eligible.

Exclusion Criteria:
  • Patients who have undergone intravenous thrombolysis or mechanical thrombectomy

  • Patients who are planned for transfer to the intensive care unit

  • Subarachnoid haemorrhage

  • Participation in an interventional medical investigation or clinical trial currently or within the past 3 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Murtala Muhammad Specialist Hospital Kano Kano State Nigeria 3200
2 Federal Medical Centre Lokoja Kogi State Nigeria 1001
3 Hospital de Apoyo II-2 Sullana Piura Peru
4 Hospital de la Amistad Peru Corea Santa Rosa II-2 Piura Peru

Sponsors and Collaborators

  • The George Institute
  • World Heart Federation

Investigators

  • Principal Investigator: Carlos Abanto, Dr, National Institute of Neurological Sciences, Lima, Peru
  • Principal Investigator: Kolawawole Wahab, Professor, University of Ilorin & University of Ilorin Teaching Hospital Ilorin, Nigeria
  • Principal Investigator: Hasan Farhan, Professor, President of Iraqi Scientific Council of Cardiology,Iraq
  • Principal Investigator: Yi Sui, Dr, Shenyang First People's Hospital Hospital Affiliated Brain Hospital
  • Principal Investigator: Saima Hilal, A/Professor, National University, Singapore
  • Principal Investigator: Lily Song, Dr, The George Institute of Global Health, China
  • Principal Investigator: Craig Anderson, Professor, Executive Director The George Institute for Global Health - China

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The George Institute
ClinicalTrials.gov Identifier:
NCT04157231
Other Study ID Numbers:
  • GI_NM-01-2019
First Posted:
Nov 8, 2019
Last Update Posted:
Sep 28, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by The George Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 28, 2021